Global Health Limited has announced a scheduled virtual meeting with Permodalan Nasional Berhad (PNB), Malaysia, as part of its ongoing investor engagement activities. The meeting is organized under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The company's management will participate in a structured investor interaction with the Malaysian institutional investor. The meeting details are as follows:

Regulatory Compliance

Global Health Limited has emphasized its commitment to regulatory compliance by ensuring that no unpublished price sensitive information will be shared during the meeting. This adherence to SEBI guidelines demonstrates the company's transparent approach to investor communications.

The company has also noted that the meeting schedule is subject to change in case of unforeseen circumstances on the part of analysts, investors, or the company itself. This flexibility clause provides necessary operational adaptability while maintaining professional commitment to stakeholder engagement.

Corporate Communication

The announcement was formally communicated to both BSE Limited and National Stock Exchange of India Limited through proper regulatory channels. Company Secretary and Compliance Officer Rahul Ranjan signed the official communication, ensuring proper corporate governance protocols were followed in the disclosure process.

Global Health Limited's board has approved significant expansion initiatives including a ₹322 crore medical college project and finalized agreements for a ₹550 crore, 400-bed hospital in central Varanasi. The board meeting held on March 25, 2026, marked major strategic developments for the healthcare provider's growth in Uttar Pradesh.

Board Meeting Outcomes and Strategic Decisions

The board addressed two major initiatives during its meeting. The company received approval to establish a medical college directly through Global Health Limited, following revised National Medical Commission regulations that now permit any company to establish medical colleges. This development allows the company to abandon its earlier Section 8 subsidiary approach through Global Health Institute of Medical Sciences Foundation.

The board also approved signing definitive agreements with Shripal Hospitality LLP for a build-to-suit development and lease arrangement for the Varanasi hospital project.

Medical College Development Initiative

The medical college project represents a strategic shift in Global Health's approach to medical education. Initially, the company had incorporated Global Health Institute of Medical Sciences Foundation as a Section 8 subsidiary on March 30, 2024, to establish medical and healthcare educational institutions. However, revised NMC regulations now permit any company to establish medical colleges, removing the earlier restriction to Section 8 companies only.

The ₹322 crore investment aims to build a strong pipeline of skilled medical professionals while enhancing regional healthcare infrastructure and improving access to quality care.

Varanasi Hospital Development Agreement

Under the build-to-suit arrangement, Shripal Hospitality will develop the hospital's civil infrastructure according to Global Health's specifications, while the company will invest in deposits, MEP systems, interior fit-outs, and medical equipment. The 400-bed facility will be strategically located on freehold land in central Varanasi, positioned to serve over 4 million people in the city and adjoining regions.

The hospital addresses a significant healthcare gap in eastern Uttar Pradesh, where existing facilities typically operate at smaller scales of 50-150 beds. The proposed construction is expected to be completed within 4 years, subject to necessary statutory and customary approvals.

Capacity Expansion and Market Positioning

As of December 31, 2025, Medanta operates 3,579 beds across its network in Gurugram, Indore, Ranchi, Lucknow, Patna, and Noida. The Varanasi addition will bring approximately 400 additional beds once operational, strengthening the company's presence in India's most populous state.

Strategic Rationale and Leadership Vision

Dr. Naresh Trehan, Chairman and Managing Director, emphasized the expansion's significance in enhancing access to advanced healthcare in a densely populated region. The facility will serve as a key healthcare hub for Eastern Uttar Pradesh, complementing existing operations in Lucknow and Noida.

Pankaj Sahni, Group CEO, highlighted Varanasi as a significantly underserved market for quality healthcare, noting that patients often travel outside the city for advanced treatments. Upon completion, this expansion will position Global Health among the largest private hospital networks in Uttar Pradesh, with approximately 1,900 beds across the state.